Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Prodia Widyahusada Tbk Receipts from Customers Related Terms
PT Prodia Widyahusada Tbk Receipts from Customers Historical Data
* Premium members only.
The historical data trend for PT Prodia Widyahusada Tbk's Receipts from Customers can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk Receipts from Customers Chart
PT Prodia Widyahusada Tbk Receipts from Customers Calculation
A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Receipts from Customers represents payment received from customers in the direct cash flow method.
Receipts from Customers for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp2,326,163 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Receipts from Customers of Rp2,326,163 Mil mean?
PT Prodia Widyahusada Tbk (ISX:PRDA) has a Receipts from Customers of Rp2,326,163 Mil as of Jun. 2026. Receipts from Customers represents payment received from customers in the direct cash flow method. View historical data for PT Prodia Widyahusada Tbk and its competitors.
Is PT Prodia Widyahusada Tbk's Receipts from Customers too high?
PT Prodia Widyahusada Tbk's current Receipts from Customers is Rp2,326,163 Mil. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Receipts from Customers compare to TMO and DHR?
PT Prodia Widyahusada Tbk's Receipts from Customers of Rp2,326,163 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receipts from Customers for a Medical Diagnostics & Research company?
A good Receipts from Customers depends on the Medical Diagnostics & Research industry context. However, Receipts from Customers should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receipts from Customers mean?
A high Receipts from Customers can signal that a stock is expensive relative to its fundamentals. Receipts from Customers represents payment received from customers in the direct cash flow method. View historical data for PT Prodia Widyahusada Tbk and its competitors. PT Prodia Widyahusada Tbk's current Receipts from Customers is Rp2,326,163 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk (ISX:PRDA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp3,063.09, compared to a current price of Rp2,490.00 — trading 18.7% below its estimated fair value. The current Receipts from Customers is Rp2,326,163 Mil. PT Prodia Widyahusada Tbk's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receipts from Customers calculated?
Receipts from Customers is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (ISX:PRDA), the current Receipts from Customers is Rp2,326,163 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Prodia Widyahusada Tbk (ISX:PRDA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk stock appears to be undervalued.
The current stock price of Rp2,490.00 is trading 18.7% below its estimated GF Value™ of Rp3,063.09.
GuruFocus considers PT Prodia Widyahusada Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRDA:
Receipts from Customers: Rp2,326,163 Mil
GF Value™: Rp3,063.09 vs. price of Rp2,490.00 (18.7% below fair value)
No single metric tells the full story. See the ISX:PRDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
81GF Score
Get the complete analysis for ISX:PRDA
Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRDA has been successfully added to your 
